Your Partner for Growth

In addition to capital, our team of experts works with ecosystem partners across our network in order to help our companies prepare for follow-on funding, scale their teams, and develop their boards and advisors. Additionally, our entrepreneurs are joining a family of early-stage companies in which to share, learn, and grow.

What We Do

Michigan’s Go-To Source for Early-Stage Capital

We provide early-stage investment to promising Michigan-based, high-tech startups, as well as programs that strengthen the startup ecosystem. Since 2009, we have invested in over 200 companies with 14 exits, deployed more than $21 million through multiple funds, and leveraged over $1 billion in additional investment.

Learn about Our Funds
 
54%
diverse founders
$21M
total deployed
200+
startups supported
$1B
dollars leveraged
14
exits

Portfolio Companies

Industry

Software-B2B

Year Funded

2019

About

Powering every UAS operation. Airspace Link is a Detroit-based start up helping local and state governments safely integrate drones into their communities.

Industry

Life Science

Year Funded

2019

About

Functional Fluidics is a biotechnology company with a high complexity CLIA-certified diagnostic lab striving to be the gold standard in red blood cell (RBC) health: beginning with Sickle Cell Disease.

Industry

Life Science

Year Funded

2020

About

Asalyxa Bio is a biotech platform company developing nano-engineered and immune-cell targeted therapeutics to treat a wide range of poorly treated and serious inflammatory diseases.

Previous ArrowPrevious Slide Next ArrowNext Slide
  • Industry

    Software-B2B

    Year Funded

    2019

    About

    Powering every UAS operation. Airspace Link is a Detroit-based start up helping local and state governments safely integrate drones into their communities.

  • Industry

    Life Science

    Year Funded

    2019

    About

    Functional Fluidics is a biotechnology company with a high complexity CLIA-certified diagnostic lab striving to be the gold standard in red blood cell (RBC) health: beginning with Sickle Cell Disease.

  • Industry

    Life Science

    Year Funded

    2020

    About

    Asalyxa Bio is a biotech platform company developing nano-engineered and immune-cell targeted therapeutics to treat a wide range of poorly treated and serious inflammatory diseases.